Sign in

Alan Felder

Independent Trustee at DIVERSIFIED HEALTHCARE TRUST
Board

About Alan Felder

Alan Felder (age 53) is an Independent Trustee of Diversified Healthcare Trust (DHC), first appointed in 2025. He brings over two decades of real estate and investment banking experience, including leadership in capital markets, M&A, and private financing. Education not disclosed in the proxy profile. Core credentials include financial expertise, investment expertise, and deep CRE/REIT experience; he currently serves on DHC’s Audit Committee as a member .

Past Roles

OrganizationRoleTenureCommittees/Impact
UBS Investment BankManaging Director, Head of Real Estate, Lodging & Leisure, Americas2016–2024Led sector coverage; capital raising and strategic transactions
UBS Investment BankManaging Director, Head of Private Financing Markets2019–2024Structured private financings (concurrent with sector head role)
UBS Investment BankManaging Director, Mergers & Acquisitions2008–2016Executed M&A advisory mandates
Donaldson, Lufkin & Jenrette (DLJ)Investment Banking Division1993–1999Investment banking roles

External Roles

OrganizationRoleTenureNotes
No other RMR public client boards; no other non-RMR public boards disclosed

Board Governance

  • Independence: The Board determined Mr. Felder meets Nasdaq/SEC independence standards and DHC’s governance definitions; no material relationship with DHC, The RMR Group Inc., or other RMR clients was found that could impair judgment .
  • Committee assignments: Audit Committee member (effective March 20, 2025); Audit Committee chaired by Dawn K. Neher; 8 meetings in 2024 (Felder joined in 2025) .
  • Expected 2025 board composition: Independent Trustee; listed on the slate of nominees for 2025 .
  • Board activity/engagement context: Board held 6 meetings in 2024; each then-serving trustee attended ≥75% of board/committee meetings; independent trustees meet in executive session at least twice annually; Lead Independent Trustee is Lisa Harris Jones .

Fixed Compensation

ComponentAmountDetail/Timing
Annual cash retainer (Independent Trustee)$85,000Standard annual fee for Independent Trustees
Committee Chair fees (if applicable)Audit: $20,000; Compensation: $15,000; Nominating & Governance: $15,000Only applies if chairing; Felder is not a chair
Lead Independent Trustee fee (if applicable)$17,500Only for Lead Independent Trustee (not Felder)
Equity retainer (annual)$90,000 in common shares37,037 shares granted in 2024 to each then‑serving trustee; fully vested at grant
2024 compensation statusFelder joined in 2025 and “did not receive any compensation in 2024”

Performance Compensation

Directors are not on performance-based pay plans. Annual equity grants to trustees are service-based and fully vested at grant; no performance metrics (TSR, EBITDA, etc.) apply to director equity awards .

Performance MetricFY2024 TargetFY2024 ResultPayout Impact
Not applicable to non‑employee directorsNo performance conditions on director equity; awards vest immediately

Other Directorships & Interlocks

CategoryDetail
Other public company boardsNone disclosed
RMR client boardsNone
Potential interlocksNone identified; board independence affirmed

Expertise & Qualifications

  • Capital markets and investment banking leadership (sector head, private financing, M&A)
  • Financial and investment expertise; CRE/REIT experience
  • Risk oversight orientation via Audit Committee service

Equity Ownership

HolderShares Beneficially Owned% OutstandingNotes
Alan Felder<1%Reported as “—” as of March 13, 2025
Trustee stock ownership guideline100,000 sharesMust be met within four years of initial election; as of March 13, 2025, all trustees have met or are expected to meet guidelines
HedgingProhibitedHedging in DHC securities prohibited by Insider Trading Policy

Governance Assessment

  • Strengths

    • Independence confirmed; no material relationships with RMR or RMR clients (key given DHC’s external management) .
    • Relevant financial and CRE expertise; immediate placement on Audit Committee supports board oversight of reporting, risk, and controls .
    • No other public board roles; minimizes interlocks and potential time/attention conflicts .
  • Watch items

    • Ownership alignment: zero reported beneficial ownership as of the 2025 record date; he is expected to build holdings to meet the 100,000-share guideline within the required window .
    • New appointee: no 2024 attendance record (joined 2025); Audit Committee had 8 meetings in 2024, so monitoring future engagement/attendance will be important .
    • External manager context: DHC is managed by The RMR Group; while committees are fully independent and oversee agreements, the structure warrants continued scrutiny for related‑party dynamics and incentive alignment (RMR fee design and oversight) .
  • Red flags observed

    • None specific to Mr. Felder disclosed; no related‑party transactions or conflicts involving him are identified in the proxy, and independence was affirmatively determined .